Zayani Sims

990 total citations
10 papers, 401 citations indexed

About

Zayani Sims is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Zayani Sims has authored 10 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 6 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Zayani Sims's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Zayani Sims is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Zayani Sims collaborates with scholars based in United States and Nigeria. Zayani Sims's co-authors include Anu Osinusi, Shyam Kottilil, Henry Masur, Anita Kohli, Amy Nelson, Sreetha Sidharthan, John G. McHutchison, Eric G. Meissner, Chloe Gross and Phillip S. Pang and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

Zayani Sims

10 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zayani Sims United States 7 373 332 69 47 24 10 401
Isabelle Lonjon‐Domanec France 14 541 1.5× 522 1.6× 79 1.1× 48 1.0× 35 1.5× 37 596
Annika Kau Germany 3 372 1.0× 371 1.1× 43 0.6× 29 0.6× 9 0.4× 4 410
M. El‐Hoseiny Egypt 8 261 0.7× 231 0.7× 35 0.5× 36 0.8× 7 0.3× 8 311
Venkata Sasikiran Goteti United States 6 321 0.9× 303 0.9× 49 0.7× 62 1.3× 8 0.3× 10 350
Mark S. Sulkowski United States 7 383 1.0× 344 1.0× 81 1.2× 21 0.4× 15 0.6× 14 432
U. Alshüth Germany 10 603 1.6× 585 1.8× 75 1.1× 62 1.3× 19 0.8× 31 678
Antonio Carlotto Italy 7 265 0.7× 324 1.0× 65 0.9× 15 0.3× 9 0.4× 13 360
Tiziana Tieghi Italy 8 139 0.4× 130 0.4× 36 0.5× 18 0.4× 22 0.9× 14 248
Lorena De Moliner Italy 10 374 1.0× 366 1.1× 17 0.2× 29 0.6× 23 1.0× 13 429
Ángeles Castro Spain 9 285 0.8× 262 0.8× 108 1.6× 28 0.6× 9 0.4× 19 348

Countries citing papers authored by Zayani Sims

Since Specialization
Citations

This map shows the geographic impact of Zayani Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zayani Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zayani Sims more than expected).

Fields of papers citing papers by Zayani Sims

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zayani Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zayani Sims. The network helps show where Zayani Sims may publish in the future.

Co-authorship network of co-authors of Zayani Sims

This figure shows the co-authorship network connecting the top 25 collaborators of Zayani Sims. A scholar is included among the top collaborators of Zayani Sims based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zayani Sims. Zayani Sims is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Tang, Lydia, Zayani Sims, Amy Nelson, et al.. (2016). Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment. World Journal of Hepatology. 8(31). 1318–1318. 21 indexed citations
2.
MaWhinney, Samantha, et al.. (2016). Effects of ribavirin/sofosbuvir treatment and ITPA phenotype on endogenous purines. Antiviral Research. 138. 79–85. 2 indexed citations
3.
Urban, Thomas, Shyam Kottilil, Eric G. Meissner, et al.. (2016). Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels. The Journal of Clinical Pharmacology. 57(1). 118–124. 6 indexed citations
4.
Kohli, Anita, Rama Kapoor, Zayani Sims, et al.. (2015). Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. The Lancet Infectious Diseases. 15(9). 1049–1054. 117 indexed citations
5.
Sidharthan, Sreetha, Anita Kohli, Zayani Sims, et al.. (2015). Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy. Clinical Infectious Diseases. 60(12). 1743–1751. 72 indexed citations
6.
Wilson, Eleanor, Sarah Kattakuzhy, Sreetha Sidharthan, et al.. (2015). Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens. Clinical Infectious Diseases. 62(3). 280–288. 38 indexed citations
7.
Hahn, Katherine, Anita Kohli, Zayani Sims, & Shyamasundaran Kottilil. (2015). Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment. Open Forum Infectious Diseases. 2(3). ofv091–ofv091. 5 indexed citations
8.
Rower, Joseph E., Eric G. Meissner, Anu Osinusi, et al.. (2015). Serum and cellular ribavirin pharmacokinetic and concentration–effect analysis in HCV patients receiving sofosbuvir plus ribavirin. Journal of Antimicrobial Chemotherapy. 70(8). 2322–2329. 18 indexed citations
9.
Wilson, Eleanor, Sarah Kattakuzhy, Zayani Sims, et al.. (2015). LP09 : High efficacy of retreatment with ledipasvir and sofosbuvir in HCV patients who failed initial short course therapy with combination DAA regimens (nih synergy trial). Journal of Hepatology. 62. S267–S268. 4 indexed citations
10.
Meissner, Eric G., Y.-J. Lee, Anu Osinusi, et al.. (2014). Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients. Hepatology. 61(3). 790–801. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Lonjon‐Domanec Breakdown of academic impact, for papers by Annika Kau Breakdown of academic impact, for papers by M. El‐Hoseiny Breakdown of academic impact, for papers by Venkata Sasikiran Goteti Breakdown of academic impact, for papers by Mark S. Sulkowski Breakdown of academic impact, for papers by U. Alshüth Breakdown of academic impact, for papers by Antonio Carlotto Breakdown of academic impact, for papers by Tiziana Tieghi Breakdown of academic impact, for papers by Lorena De Moliner Breakdown of academic impact, for papers by Ángeles Castro
Rankless by CCL
2026